FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Verizon reports strong Q3 results, reaffirms guidance, and outlines a customer-centric growth strategy under new CEO.
Character.AI to ban under-18 users from open-ended chats by November 2025, amid regulatory scrutiny and lawsuits over harmful content.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Verizon reports strong Q3 results, reaffirms guidance, and outlines a customer-centric growth strategy under new CEO.
Character.AI to ban under-18 users from open-ended chats by November 2025, amid regulatory scrutiny and lawsuits over harmful content.